Why nootropics group into mechanism classes
The compounds people label as nootropics do not share a single mode of action. Stimulants such as caffeine work largely by blocking adenosine receptors, cholinergics like citicoline supply substrate for acetylcholine, racetams appear to modulate glutamate AMPA receptors, herbals such as bacopa act over weeks through several pathways, and peptidic agents target their own receptor systems. Grouping them by mechanism is more informative than a single ranked list, because focus, mood, and memory effects come from different biology.
Evidence quality also varies sharply by class. Caffeine has decades of controlled trials, while many racetams and peptides rest on small or older studies, often outside the populations using them today.
Reading focus, mood, and side-effect tradeoffs together
A profile matrix is useful because a high focus score often travels with a higher side-effect or tolerance cost, as with stimulants. Calmer agents may score lower on acute focus but carry fewer downsides. No single column tells the whole story; the value is in seeing the tradeoffs side by side rather than chasing one metric.
This is general educational information, not medical advice. Many of these substances are unregulated, interact with medications, and are unsuitable in pregnancy or with cardiovascular or psychiatric conditions. Consult a qualified clinician before use.